Nonoperating Income (Expense) of Biohaven Ltd. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary: Biohaven Ltd. quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
Biohaven Ltd. Nonoperating Income (Expense) for the quarter ending 31 Dec 2025 was $2,470,000, a 179% decline year-over-year.
Biohaven Ltd. Nonoperating Income (Expense) for the twelve months ending 31 Dec 2025 was $7,998,000, a 80% decline year-over-year.
Biohaven Ltd. annual Nonoperating Income (Expense) for 2025 was $7,998,000, a 80% decline from 2024.
Biohaven Ltd. annual Nonoperating Income (Expense) for 2024 was $39,424,000, a 49% increase from 2023.
Biohaven Ltd. annual Nonoperating Income (Expense) for 2023 was $26,500,000.
Source SEC data: View on sec.gov

Nonoperating Income (Expense), Trailing 12 Months (USD)

Nonoperating Income (Expense), Quarterly (USD)

Nonoperating Income (Expense), YoY Quarterly Change (%)

Nonoperating Income (Expense), Annual (USD)

Nonoperating Income (Expense), YoY Annual Change (%)

Biohaven Ltd. Quarterly Nonoperating Income (Expense) (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$7,998,000	$2,470,000	-$5,606,000	-179%	01 Oct 2025	31 Dec 2025	10-K	02 Mar 2026	2025	FY
Q3 2025	$13,604,000	$3,840,000	-$21,645,000	-122%	01 Jul 2025	30 Sep 2025	10-Q	10 Nov 2025	2025	Q3
Q2 2025	$35,249,000	$13,815,000	-$363,000	-2.6%	01 Apr 2025	30 Jun 2025	10-Q	11 Aug 2025	2025	Q2
Q1 2025	$35,612,000	$493,000	-$3,812,000	-89%	01 Jan 2025	31 Mar 2025	10-Q	12 May 2025	2025	Q1
Q4 2024	$39,424,000	$3,136,000	-$4,607,000	-59%	01 Oct 2024	31 Dec 2024	10-K	02 Mar 2026	2025	FY
Q3 2024	$44,031,000	$17,805,000	+$13,119,000	+280%	01 Jul 2024	30 Sep 2024	10-Q	10 Nov 2025	2025	Q3
Q2 2024	$30,912,000	$14,178,000	+$8,336,000	+143%	01 Apr 2024	30 Jun 2024	10-Q	11 Aug 2025	2025	Q2
Q1 2024	$22,576,000	$4,305,000	-$3,924,000	-48%	01 Jan 2024	31 Mar 2024	10-Q	12 May 2025	2025	Q1
Q4 2023	$26,500,000	$7,743,000	+$5,585,000	+259%	01 Oct 2023	31 Dec 2023	10-K	02 Mar 2026	2025	FY
Q3 2023	$20,915,000	$4,686,000	+$4,686,000		01 Jul 2023	30 Sep 2023	10-Q	12 Nov 2024	2024	Q3
Q2 2023	$16,229,000	$5,842,000	+$5,909,000		01 Apr 2023	30 Jun 2023	10-Q	09 Aug 2024	2024	Q2
Q1 2023	$10,320,000	$8,229,000	+$12,229,000		01 Jan 2023	31 Mar 2023	10-Q	12 May 2023	2023	Q1
Q4 2022	$1,909,000	$2,158,000			01 Oct 2022	31 Dec 2022	10-K	03 Mar 2025	2024	FY
Q3 2022		$0	+$5,000,000		01 Jul 2022	30 Sep 2022	10-Q	09 Nov 2022	2022	Q3
Q2 2022		$67,000			01 Apr 2022	30 Jun 2022	10-Q	31 Jul 2023	2023	Q2
Q1 2022		$4,000,000			01 Jan 2022	31 Mar 2022	10-Q	12 May 2023	2023	Q1
Q3 2021		$5,000,000			01 Jul 2021	30 Sep 2021	10-Q	09 Nov 2022	2022	Q3

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$7,998,000	-$31,426,000	-80%	01 Jan 2025	31 Dec 2025	10-K	02 Mar 2026	2025	FY
2024	$39,424,000	+$12,924,000	+49%	01 Jan 2024	31 Dec 2024	10-K	02 Mar 2026	2025	FY
2023	$26,500,000	+$28,409,000		01 Jan 2023	31 Dec 2023	10-K	02 Mar 2026	2025	FY
2022	$1,909,000	-$8,379,000	-130%	01 Jan 2022	31 Dec 2022	10-K	03 Mar 2025	2024	FY
2021	$6,470,000	+$10,632,000		01 Jan 2021	31 Dec 2021	10-K	29 Feb 2024	2023	FY
2020	$4,162,000			01 Jan 2020	31 Dec 2020	10-K	23 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.